Quanterix (NASDAQ: QTRX) — Perfil da empresa, notícias e dados financeiros
Quanterix delivers high-definition diagnostics for disease detection, focusing on revolutionizing insights in neurology and oncology.

Quanterix
Quanterix (NASDAQ:QTRX) specializes in providing high-definition diagnostics with a focus on developing technologies that enable deeper insights into disease biology. This capability allows for the detection and quantification of biomarkers at levels previously undetectable, a breakthrough with significant implications for medical research, diagnostics, and therapeutic development. The company's projects encompass a broad range of applications, from neurology and oncology to cardiology, aiming to revolutionize the approach to disease detection and monitoring. Quanterix's objectives include advancing precision health by empowering its customers with robust, scalable, and sensitive tools that enhance clinical outcomes and accelerate research and development in life sciences.
Resumo
Operações
Produtos e/ou serviços de Quanterix
- Simoa HD-X Analyzer, an advanced ultrasensitive biomarker detection system enabling research in diagnostics and drug development.
- Simoa Assay Kits, designed for precise measurement of biomolecules, critical for neurology and oncology research.
- Homebrew Assay Development Kit, offering researchers the tools to develop custom assays for specialized biomarker detection.
- Simoa Accelerator Lab, a service providing expertise in developing and running Simoa assays for biomarker research.
- Neurology Research Solutions, focused on detecting neurological biomarkers to advance research in neurodegenerative diseases.
- Oncology Research Solutions, aimed at improving cancer detection and research through ultra-sensitive biomarker analysis.
equipe executiva do Quanterix
- William P. DonnellyExecutive Chair
- David R. WaltCo-Founder & Chairman of Scientific Advisory Board
- Everett V. CunninghamPresident, CEO & Director
- Jason FaesslerCFO & Treasurer
- Anthony CatalanoChief Operating Officer
- Michael MillerChief Technology & Products Officer
- Joshua YoungHead of Investor Relations
- Daniel S. CharChief Legal Officer & Corporate Secretary
- Erica BellChief People Officer
- Naren BhatChief Strategy Officer
Principais indicadores financeiros
Resultados divulgados pela Quanterix , em USD.
- Cap. de mercado
- 136,7 mi
- Receita (TTM)
- 153,4 mi
- P/L
- —
- LPA (diluído, TTM)
- -2.6
- Dividend yield
- —
- Margem de lucro
- -80.3%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 138,7 mi | -109,8 mi | -107,2 mi | |
| 135,4 mi | -52,6 mi | -38,5 mi | |
| 121,1 mi | -46 mi | -28,4 mi | |
| 105,5 mi | -104,3 mi | -99,6 mi |